The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124820204 12482020 4 F 20160305 20160805 20160620 20160816 PER US-INCYTE CORPORATION-2016IN001364 INCYTE 51.97 YR F Y 55.33000 KG 20160816 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124820204 12482020 1 PS JAKAFI RUXOLITINIB 1 Oral 10 MG, BID U U AE2923F 202192 10 MG TABLET
124820204 12482020 2 SS JAKAFI RUXOLITINIB 1 Oral 15 MG, QD U U 202192 15 MG TABLET
124820204 12482020 3 SS JAKAFI RUXOLITINIB 1 Oral 10 MG, BID U U 1403292AA 202192 10 MG TABLET
124820204 12482020 4 SS JAKAFI RUXOLITINIB 1 Oral 10 MG, BID U U AE2924F 202192 10 MG TABLET
124820204 12482020 5 SS JAKAFI RUXOLITINIB 1 Oral 10 MG, BID U U 140263188 202192 10 MG TABLET
124820204 12482020 6 SS AMBIEN ZOLPIDEM TARTRATE 1 0
124820204 12482020 7 C BABY ASPIRIN ASPIRIN 1 0
124820204 12482020 8 C LEXAPRO ESCITALOPRAM OXALATE 1 0
124820204 12482020 9 C LISINOPRIL. LISINOPRIL 1 0
124820204 12482020 10 C MVI VITAMINS 1 0
124820204 12482020 11 C VITAMIN B12 CYANOCOBALAMIN 1 0
124820204 12482020 12 C VITAMIN B2 RIBOFLAVIN 1 0
124820204 12482020 13 C LORAZEPAM. LORAZEPAM 1 0
124820204 12482020 14 C BENADRYL DIPHENHYDRAMINE HYDROCHLORIDE 1 UNK 0
124820204 12482020 15 C ORGANIC MULTIVITAMIN 2 UNK 0
124820204 12482020 16 C ECOTRIN ASPIRIN 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124820204 12482020 1 Polycythaemia vera
124820204 12482020 6 Insomnia
124820204 12482020 7 Product used for unknown indication
124820204 12482020 8 Product used for unknown indication
124820204 12482020 9 Product used for unknown indication
124820204 12482020 10 Product used for unknown indication
124820204 12482020 11 Product used for unknown indication
124820204 12482020 12 Product used for unknown indication
124820204 12482020 13 Product used for unknown indication
124820204 12482020 14 Insomnia
124820204 12482020 15 Product used for unknown indication
124820204 12482020 16 Product used for unknown indication

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
124820204 12482020 Anxiety
124820204 12482020 Chest pain
124820204 12482020 Contusion
124820204 12482020 Dizziness
124820204 12482020 Eye pain
124820204 12482020 Fatigue
124820204 12482020 Feeling abnormal
124820204 12482020 Headache
124820204 12482020 Incorrect dose administered
124820204 12482020 Insomnia
124820204 12482020 Migraine
124820204 12482020 Nausea
124820204 12482020 Somnolence
124820204 12482020 Tinnitus

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124820204 12482020 1 20160217 0
124820204 12482020 2 20160218 0